The Evolving Diplomatic Side of Space Sustainability

On the Space to Grow podcast, Astroscale’s Chris Blackerby and Charity Weeden bring their compelling experience and expertise to map out the technology, international policy, and scalability that will define the next generation of space exploration.

 

Space sustainability includes many facets. There’s the science, and there’s the policy. However, both have to be part of the conversation to achieve objectives. Space to Grow hosts Chris Blackerby and Charity Weeden spoke with esteemed physicist and space policy leader Dr. David Kendall. Dr. Kendall was the Chair of the United Nations Committee on Peaceful Uses of Outer Space (COPUOS), the Director-General of the Canadian Space Agency, and a faculty member at the International Space University.

The hosts asked Dr. Kendall if it was harder to be a scientist or diplomat. “They are both challenging in different ways. Science is a singular activity that requires full immersion. Diplomacy puts you out there talking to people.”

Dr. Kendall had no formal plans to transition, but a conversation with his wife made him apply to become the Director-General of the Canadian Space Agency. “Then I saw the other side of the coin and how decisions are made. The space business really is a team effort, globally.”

“The legal and scientific committees don’t talk to each other but must. We also need to find a way for the commercial sector voices to be heard. And we need to move a lot faster.” -Dr. David Kendall

One of Dr. Kendall’s most significant contributions to space policy was his work on the 21 Long-Term Sustainability of Outer Space Activities guidelines. He was part of the working group and then the chair. It required all nation-state approval and was finally approved in 2019, with all 90 members saying yes.

“Creating 21 new ways of working together was an accomplishment. But there’s more to do on many issues like active debris removal and space traffic management,” Dr. Kendall said.

After serving as chair, Dr. Kendall highlighted the next challenges that the organization needed to consider. “The legal and scientific committees don’t talk to each other but must. We also need to find a way for the commercial sector voices to be heard. And we need to move a lot faster.”

Listen to Previous Episodes Here!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

 

Follow us on social media for the latest updates in B2B!

Image

Latest

personal branding
Personal Branding Now Drives B2B Success, Customer Trust, and Competitive Advantage
December 5, 2025

Personal branding has rapidly shifted from a “nice-to-have” to a strategic imperative in B2B marketing, reshaping how companies communicate, differentiate, and build trust. As industries evolve and professionals take on more dynamic, multi-stream careers, visibility and authenticity have become critical assets. Key findings from the Edelman + LinkedIn Thought Leadership Impact Report show that…

Read More
IT
Real-World IT Practices Are Streamlining AV Deployments and Raising the Bar for Consistency
December 4, 2025

For years, the AV industry has discussed the long-anticipated convergence with IT—but that shift is no longer theoretical. With cloud adoption accelerating, hybrid work normalizing, and organizations rebuilding digital infrastructure after years of rapid change, AV systems now sit squarely on the IT backbone. In fact, the majority of newly upgraded conference rooms require network-centric…

Read More
ROI
ROI Case Study
December 3, 2025

Denials are no longer a slow leak in the revenue cycle—they’re a fast-moving, rule-shifting game controlled by payers, and hospitals that don’t model denial patterns in real time end up budgeting around losses they could have prevented. PayerWatch’s four-digit, client-verified ROI in 2024 shows what happens when a hospital stops reacting claim by…

Read More
coverage
Clip 2 – Fighting for Coverage: One Patient’s Story
December 3, 2025

Health insurers love to advertise themselves as guardians of care, but the real story often begins when a patient’s life no longer fits neatly into a spreadsheet. In oncology especially, “coverage” isn’t a bureaucratic checkbox—it’s the fragile bridge between a treatment that finally works and a relapse that can undo years of grit…

Read More